Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
City of Hope, Duarte, California UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange, California Stanford Hospital & Clinics, Stanford, California BAMF Health, Inc., Grand Rapids, Michigan Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio